OtherPublishAheadOfPrint
Does 18F-FDG PET/CT Improve the Detection of Posttreatment Recurrence of Head and Neck Squamous Cell Carcinoma in Patients Negative for Disease on Clinical Follow-up?
Ronan Abgral, Solène Querellou, Gaël Potard, Pierre-Yves Le Roux, Alexandra Le Duc-Pennec, Remi Marianovski, Olivier Pradier, Yves Bizais, Françoise Kraeber-Bodéré and Pierre Y. Salaun
Journal of Nuclear Medicine December 2008, DOI: https://doi.org/10.2967/jnumed.108.055806
Ronan Abgral
Solène Querellou
Gaël Potard
Pierre-Yves Le Roux
Alexandra Le Duc-Pennec
Remi Marianovski
Olivier Pradier
Yves Bizais
Françoise Kraeber-Bodéré
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Journal of Nuclear Medicine
Vol. 65, Issue 4
April 1, 2024
Does 18F-FDG PET/CT Improve the Detection of Posttreatment Recurrence of Head and Neck Squamous Cell Carcinoma in Patients Negative for Disease on Clinical Follow-up?
Ronan Abgral, Solène Querellou, Gaël Potard, Pierre-Yves Le Roux, Alexandra Le Duc-Pennec, Remi Marianovski, Olivier Pradier, Yves Bizais, Françoise Kraeber-Bodéré, Pierre Y. Salaun
Journal of Nuclear Medicine Dec 2008, DOI: 10.2967/jnumed.108.055806
Does 18F-FDG PET/CT Improve the Detection of Posttreatment Recurrence of Head and Neck Squamous Cell Carcinoma in Patients Negative for Disease on Clinical Follow-up?
Ronan Abgral, Solène Querellou, Gaël Potard, Pierre-Yves Le Roux, Alexandra Le Duc-Pennec, Remi Marianovski, Olivier Pradier, Yves Bizais, Françoise Kraeber-Bodéré, Pierre Y. Salaun
Journal of Nuclear Medicine Dec 2008, DOI: 10.2967/jnumed.108.055806
Jump to section
Related Articles
Cited By...
- PET/CT Versus Standard Imaging for Prediction of Survival in Patients with Recurrent Head and Neck Squamous Cell Carcinoma
- Guideline Familiarity Predicts Variation in Self-Reported Use of Routine Surveillance PET/CT by Physicians Who Treat Head and Neck Cancer
- Head and Neck Cancers, Version 2.2014
- Osteoradionecrosis after Radiation Therapy for Head and Neck Cancer: Differentiation from Recurrent Disease with CT and PET/CT Imaging
- PET/CT Imaging and Human Papilloma Virus-Positive Oropharyngeal Squamous Cell Cancer: Evolving Clinical Imaging Paradigm
- Addition of 18F-FDG PET/CT to Clinical Assessment Predicts Overall Survival in HNSCC: A Retrospective Analysis with Follow-up for 12 Years
- Early Detection of Recurrent Disease by FDG-PET/CT Leads to Management Changes in Patients With Squamous Cell Cancer of the Head and Neck
- The Lack of Evidence for PET or PET/CT Surveillance of Patients with Treated Lymphoma, Colorectal Cancer, and Head and Neck Cancer: A Systematic Review
- Performance of Whole-Body PET/CT for the Detection of Distant Malignancies in Various Cancers: A Systematic Review and Meta-Analysis
- The role of positron emission tomography/CT imaging in head and neck cancer patients after radical chemoradiotherapy
- Head and Neck Cancers
- Innovations in Radiotherapy Planning of Head and Neck Cancers: Role of PET
- 18F-FDG PET as a Routine Posttreatment Surveillance Tool in Oral and Oropharyngeal Squamous Cell Carcinoma: A ProspectiveStudy